VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Novo Nordisk (NVO.US) to Limit Wegovy Shipments in China to Prevent Supply Disruptions
Novo Nordisk (NVO.US) to Limit Wegovy Shipments in China to Prevent Supply Disruptions
Jun 27, 2024 18:52 CST Updated 18:52
Share:
Novo Nordisk
Insulin Developer and Manufacturer
Gelonghui June 27 | Novo Nordisk (NVO.US): Will limit the shipment of weight-loss drug Wegovy in China to avoid supply disruptions.